Aleksandrs Zhavoronkov

Aleksandrs Zhavoronkov is the founder of InSilico Medicine Hong Kong Ltd., founded in 2014, holding the title of Co-Chief Executive Officer & Director.
Dr. Zhavoronkov was the founder of Deep Longevity Ltd., founded in 2020, holding the title of Co-Chief Executive Officer.
Dr. Zhavoronkov is the founder of InSilico Medicine, Inc., founded in 2014, holding the title of Co-Chief Executive Officer & Director.
Dr. Zhavoronkov is the founder of InSilico Medicine Cayman TopCo, founded in 2018, holding the title of Chairman & Co-Chief Executive Officer.
Dr. Zhavoronkov is the founder of LongeVC, founded in 2016, holding the title of Head of Advisory Board.
Dr. Zhavoronkov is also the founder of Insilicon Intelligent Technology (Shanghai) Co., Ltd.,Insilico Medicine IP Ltd...
Dr. Zhavoronkov is currently Director at Alliance For Artificial Intelligence In Healthcare.
Dr. Zhavoronkov is currently Trustee at Biogerontology Research Foundation.
Former positions include Sales Director at ATI Technologies ULC, Director-Business Development at Colby Pharmaceutical Co. from 2008 to 2009, and President at Mediox, Inc. Education includes an undergraduate degree from Queen's University conferred in 2009, a graduate degree from The Johns Hopkins University, and a doctorate from Moscow State University.